Objectives-The purpose of the study was to verify whether minimal concern is warranted in regard to serious adverse effects in the sleep laboratory.
INTRODUCTION
POLYSOMNOGRAPHY IS A WIDELY PERFORMED PROCEDURE USED IN THE DIAGNOSIS OF SLEEP DISORDERS AND REFERS TO THE COLLECTIVE PROCESS OF CONTINUOUS MONITORING AND RECORDING OF PHYSIOLOGIC DATA DURING SLEEP. 1 The procedure is typically performed by a trained technologist and takes place overnight in a hospital-based or a stand-alone, specially constructed laboratory.
The number of polysomnograms performed has dramatically increased over the past 20 years. During this time frame, the results of one study has indicated the occurrence of a 6-fold increase in the absolute number of patients referred to regional sleep centers for evaluation, and a greater than 20-fold increase for the diagnosis of obstructive sleep apnea, a medical condition closely associated with cardiovascular comorbidity. 2 Therefore, monitoring for the suspicion of obstructive sleep apnea might be expected to be associated with adverse events and, indeed, is the major primary diagnosis (67.8%) for referral cases to sleep centers accredited by the American Academy of Sleep Medicine. 2 A 1991 Agency for Health Care Policy and Research technology report described polysomnography as "an entirely non-invasive procedure, and would have the same degree of risk as, for example an ECG (electrocardiogram) examination." 3 On the other hand, the American Academy of Sleep Medicine accreditation standards indicate that sleep technicians should be aware that patients who are being evaluated for sleep disorders can be critically ill, and training in emergency procedures, including cardiopulmonary resuscitation, is required for accreditation. These standards state further that emergency personnel must have access to the patient including space around the bed, and a route that facilitates access for carts and equipment, and also that the sleep disorders center must have a written policy for emergencies. 4 Problems encountered during polysomnography procedures fall primarily within 2 categories: (1) those resulting from the testing equipment and methods (ie, electrode placement, latex allergy, colloid use, or electrical safety) and (2) adverse events noted by the technician or occurring to the patient during the study. These issues are listed in the literature in the form of anecdotal reports, 5 in textbooks, 6, 7 or available by website. 8 However, there have been no prospective studies examining the incidence of adverse events during polysomnography.
The purpose of the study was to verify whether minimal concern is warranted in regard to serious adverse effects in the sleep laboratory.
METHODS

Study Design
We performed a prospective multicenter study involving SleepMed Incorporated (Columbia, SC) sleep centers in 4 states (Ohio, North Carolina, South Carolina, and Tennessee). Of the 17 sites, 1 was a free-standing (American Academy of Sleep Medicine-accredited) center; 1 was at a major hospital (> 500 beds) academic center; 1 was at another urban hospital (< 500 beds) center; and 14 were at nonurban hospitals (< 500 beds), 1 of which was accredited by the American Academy of Sleep Medicine. All had standardized operations manuals and local protocols for the identification and handling of adverse events. Data were obtained from the technical scoring reports for every polysomnogram performed from January 1, 2002, to June 30, 2003, in a 4-state region.
Each study was performed by a technologist with current basic life support or advanced cardiac life support credentials. All had completed a routine 2-day training program prior to their first study to familiarize themselves with procedures and technology, and to review scoring procedures and policy. Experience level varied from months to years, and all technologists had completed national certification or were in the process of completing courses that would lead to national certification. During the study, the technologist provided a written note on observed problems, as needed, but at least every hour; in the case of titration studies, the reasons to change a pressure setting were recorded. Upon completion of the study, the technologist provided a written summary of the study that included descriptions of events including any non-emergent or emergent intervention. After the polysomnogram was completed, the record was sent to 1 of 3 different scoring teams for this regional network of 77 beds, and these teams were responsible for scoring polysomnography studies within 72 hours of receipt of the study. Results of the number of studies and the number of adverse events were tabulated from all scoring teams and reported in 6-month intervals without patient-identifying information.
Adverse events are defined as those requiring immediate medical attention (physician call or emergency room evaluation). Events found by the scoring teams, but not by the technician performing the study were noted as physician alerts and are also called adverse events for the purposes of this report. By protocol, subjects noted to have had an adverse event were contacted within 2 weeks to evaluate their condition.
An event in the fifth month of the survey prompted an intensive review by quality assurance and resulted in an educational intervention for all technologists who performed sleep studies. This was a 1-hour tutorial focused on the recognition of cardiac arrhythmias.
The study was designed and performed as a quality-control exercise across all participating sites and received an Institutional Review Board waiver for reporting of adverse events according to site. An additional Institutional Review Board waiver was obtained to report the case-fatality information at the level of detail reported in this communication.
Statistical Methods
The results involve 1 of 2 mutually exclusive outcomes with respect to morbidity and mortality; therefore, data were analyzed using a binomial distribution. SAS release 8.02 statistical software was used for analysis (SAS, Inc., Cary NC).
RESULTS
Out of 16,084 polysomnography studies, there was 1 fatality, occurring in the fifth month of the survey. This death occurred in an approximately 60-year-old man with known history of coronary artery disease, dilated cardiomyopathy (ejection fraction 20%), and chronic hypertension who had undergone an elective split-night polysomnography for the indications of suspected sleep apnea (snoring and occasional pauses during sleep, but without reported sleepiness). In 322 minutes of sleep prior to continuous positive airway pressure application, the respiratory-disturbance index was 37 events per hour associated with a nadir oxygen saturation of 80%. The cardiac arrest occurred during sleep in the early morning, 101 minutes after application of continuous positive airway pressure with a respiratory disturbance index < 5 and a lowest oxygen saturation value of 91%. Retrospective analysis showed premature ventricular beats before and after application of continuous positive airway pressure and brief (< 6 seconds) episodes of polymorphic ventricular tachycardia (Figure 1) , occurring 45 and 30 minutes before sustained ventricular tachycardia leading to fibrillation ( Figure 2 ). The latter precipitated an emergency code, which was judged to be properly conducted, but from which the patient could not be resuscitated.
In the remaining studies, there were 28 instances during a polysomnogram in which the patient had symptoms or observed problems that prompted the technologist to ask for an immediate physician evaluation or to transfer the patient to an emergency care facility. Most adverse events were arrhythmias and were associated with sleep-disordered breathing, with shortness of breath and chest pain occurring in only one patient. In another 28 instances, findings of complex ventricular arrhythmia were noted by one of the members of the scoring team during the review of the polysomnography, and the referring physician was alerted to this finding (Figure 3) . Table 1 presents the results of the binomial model for mortality, events noted during the polysomnography, events noted by scorers, and all events.
None of these 56 adverse events were associated with mortality within at least 2 weeks of the polysomnogram. Adverse events were not related to the number of beds in the facility or to the length of time that the facility had been performing sleep studies.
DISCUSSION
We report the first formal prospective evaluation of the incidence of major adverse events in the sleep laboratory. Our findings of a very low event rate are consistent with information from anecdotal reports, textbook, and regulatory websites. 6, 7 The mortality rate during or 2 weeks after an adverse event was approximately 0.006%, and the overall adverse event rate was 0.35%. These rates are not statistically significant from 0, as demonstrated by the confidence intervals ( Table 1 ). This study involved a range of sites similar to that of sites found in other regions of the country, and, like most centers, 2 the experience is that these sites test a majority of patients for sleep-disordered breathing.
As a medical procedure, electrocardiography is probably associated with the lowest rate of problems, such as local skin reactions, particularly contact dermatitis, allergic reactions to acrylate, burns (during magnetic resonance imaging), and hyperpigmentation [9] [10] [11] [12] [13] [14] ; there is 1 report of life-threatening anaphylaxis by electrocardiogram electrode material. 15 Other procedures such as bronchoscopy have been associated with arrhythmias, particularly in situations of a preexisting history of arrhythmia. 16 Interestingly, it is recommended that oximetry and electrocardiogram monitoring accompany bronchoscopy. 17 The mortality rate during bronchoscopy ranges from 0% to 0.05%, within the range we noted with polysomnography. 18, 19 However, unlike bronchoscopy or for that matter other procedures such as cardiac catheterization or colonoscopy, polysomnography is noninvasive. Polysomnography, however, is often performed in patients with substantial cardiovascular comorbidity, including hypertension, coronary artery disease, congestive heart failure, stroke, and diabetes mellitus. [20] [21] [22] [23] [24] [25] Hence, a risk for cardiac events could be presumed with polysomnography when obstructive sleep apnea is the most common indication. 2 Immediate case finding for potentially important cardiac events during a polysomnogram is dependent at the present time on technologist awareness and the recognition of such events as the patient is recorded in the laboratory. The attention of the technologist can be distracted from the paper or computer record by equipment maintenance, adjustment of leads, titration of positive pressure, or nonemergent patient needs or concerns; in addition, technologists are asked to be vigilant for prolonged periods of time, which may lead to fatigue, and often are responsible for more than one patient. Unlike monitoring systems in place in the intensive care unit, current systems for computerized acquisition of data are not constructed or approved for arrhythmia detection during polysomnography (Food and Drug Administration, personal communication by electronic mail, David Banks, FDA Office of Special Health Issues). Theoretically, new technology or better identification of specific types of patients at greater or lesser risk for having adverse events could be appropriate, but justification of any added expense was not in the scope of the present report. Results from this study may not be applicable to those centers that focus exclusively on patients with the highest cardiovascular or neurologic comorbidity.
Despite the rarity of adverse events; training, written procedures, basic life support certification, continuing education, and procedures for handling medical emergencies or adverse events noted during polysomnography or in scoring are prudent, and those individuals who conduct polysomnograms for research purposes should be prepared for the possibility of adverse events. Diagram of study adverse events. 
